Cerevel Therapeutics Holdings Inc (NASDAQ: CERE) is 1.18% higher on its value in year-to-date trading and has touched a low of $19.59 and a high of $43.59 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The CERE stock was last observed hovering at around $42.70 in the last trading session, with the day’s gains setting it 0.2%.
Currently trading at $42.90, the stock is 4.42% and 3.94% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.17 million and changing 0.47% at the moment leaves the stock 13.90% off its SMA200. CERE registered 47.37% gain for a year compared to 6-month loss of 1.44%.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 2.51% gain in the last 1 month and extending the period to 3 months gives it a 1.80%, and is 6.43% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 2.02% over the week and 2.66% over the month.
Cerevel Therapeutics Holdings Inc (CERE) has around 334 employees, a market worth around $7.82B and $0.00M in sales. Distance from 52-week low is 118.99% and -1.58% from its 52-week high. The company has generated returns on investments over the last 12 months (-44.14%).
The EPS is expected to grow by 1.87% this year.
Cerevel Therapeutics Holdings Inc (CERE) Top Institutional Holders
The shares outstanding are 181.36M, and float is at 87.51M with Short Float at 7.53%.
Cerevel Therapeutics Holdings Inc (CERE) Insider Activity
The most recent transaction is an insider sale by COLES N ANTHONY,the company’sDirector. SEC filings show that COLES N ANTHONY sold 25,000 shares of the company’s common stock on Jul 01 ’24 at a price of $41.18 per share for a total of $1.03 million. Following the sale, the insider now owns 25928.0 shares.
Cerevel Therapeutics Holdings Inc disclosed in a document filed with the SEC on Jun 03 ’24 that COLES N ANTHONY (Director) sold a total of 50,000 shares of the company’s common stock. The trade occurred on Jun 03 ’24 and was made at $40.61 per share for $2.03 million. Following the transaction, the insider now directly holds 15638.0 shares of the CERE stock.
Still, SEC filings show that on May 10 ’24, COLES N ANTHONY (Director) disposed off 50,000 shares at an average price of $42.10 for $2.11 million. The insider now directly holds 15,638 shares of Cerevel Therapeutics Holdings Inc (CERE).
